Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul;123(1):148-154.
doi: 10.1038/s41416-020-0831-9. Epub 2020 Apr 27.

Trends in cervical cancer incidence in sub-Saharan Africa

Affiliations

Trends in cervical cancer incidence in sub-Saharan Africa

Elima Jedy-Agba et al. Br J Cancer. 2020 Jul.

Abstract

Background: Cervical cancer is the second most common cancer and the leading cause of cancer death in women in sub-Saharan Africa (SSA).

Methods: Trends in the incidence of cervical cancer are examined for a period of 10-25 years in 10 population-based cancer registries across eight SSA countries (Gambia, Kenya, Malawi, Mauritius, Seychelles, South Africa, Uganda and Zimbabwe). A total of 21,990 cases of cervical cancer were included in the analyses.

Results: Incidence rates had increased in all registries for some or all of the periods studied, except for Mauritius with a constant annual 2.5% decline. Eastern Cape and Blantyre (Malawi) registries showed significant increases over time, with the most rapid being in Blantyre (7.9% annually). In Kampala (Uganda), a significant increase was noted (2.2%) until 2006, followed by a non-significant decline. In Eldoret, a decrease (1998-2002) was followed by a significant increase (9.5%) from 2002 to 2016.

Conclusion: Overall, cervical cancer incidence has been increasing in SSA. The current high-level advocacy to reduce the burden of cervical cancer in SSA needs to be translated into support for prevention (vaccination against human papillomavirus and population-wide screening), with careful monitoring of results through population-based registries.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Cervical cancer age standardized incidence rates by year of diagnosis, with best fitting regression line, and corresponding coefficients of determination (R2).
Fig. 2
Fig. 2
Cervical cancer age standardised incidence rate (ASR) (with 95% confidence intervals) in Seychelles and Bulawayo, by period of diagnosis.
Fig. 3
Fig. 3
Age-specific incidence rates from recent time periods, 10 registries.
Fig. 4
Fig. 4
Age-specific incidence rate (ASR) of cervical cancer in Harare and Kampala by period of diagnosis (a) and by birth cohort (b).

Similar articles

Cited by

References

    1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018;68:394–424. doi: 10.3322/caac.21492. - DOI - PubMed
    1. International Agency for Research on Cancer (IARC). GLOBOCANhttp://gco.iarc.fr/tomorrow/home (2018).
    1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. cancer. 2010;127:2893–2917. doi: 10.1002/ijc.25516. - DOI - PubMed
    1. Huh WK, Ault KA, Chelmow D, Davey DD, Goulart RA, Garcia FA, et al. Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance. Gynecol. Oncol. 2015;136:178–182. doi: 10.1016/j.ygyno.2014.12.022. - DOI - PubMed
    1. Isa Modibbo F, Dareng E, Bamisaye P, Jedy-Agba E, Adewole A, Oyeneyin L, et al. Qualitative study of barriers to cervical cancer screening among Nigerian women. BMJ Open. 2016;6:e008533. doi: 10.1136/bmjopen-2015-008533. - DOI - PMC - PubMed

Publication types

Substances